Table 5.
Distribution of ESBL types and virulence factors of the 57 ESBL-KP isolates from 2004 to 2005
| ESBL type | Number (n = 57) | HV (n = 5) | rmpA (n = 12) | rmpA2 (n = 12) | K1 capsule (n = 5) | K2 capsule (n = 1) |
|---|---|---|---|---|---|---|
| TEM-like | 2 | 0 | 0 | 0 | 0 | 0 |
| SHV-2a | 2 | 0 | 0 | 0 | 0 | 0 |
| SHV-2a + CTX-M-3 | 1 | 0 | 0 | 0 | 0 | 0 |
| SHV-5 + TEM-1 | 2 | 0 | 2 | 1 | 0 | 0 |
| SHV-5 | 27 | 3 | 3 | 3 | 0 | 1 |
| 0 | 2 | 2 | 2 | 0 | ||
| 0 | 1 | 0 | 1 | 0 | ||
| 0 | 0 | 1 | 0 | 0 | ||
| 1 | 0 | 0 | 0 | 0 | ||
| SHV-5 + CTX-M-3 + TEM-1 | 1 | `0 | 0 | 0 | 0 | 0 |
| SHV-5 + CTX-M-3 | 1 | 0 | 0 | 1 | 0 | 0 |
| SHV-5 + CTX-M-15 + TEM-1 | 1 | 0 | 0 | 0 | 0 | 0 |
| SHV-12 | 7 | 0 | 2 | 3 | 0 | 0 |
| SHV-12 + CTX-M-15 | 1 | 0 | 0 | 0 | 0 | 0 |
| CTX-M-3+ SHV-11 | 1 | 1 | 1 | 1 | 0 | 0 |
| CTX-M-3 + TEM-1 | 3 | 0 | 1 | 0 | 0 | 0 |
| CTX-M-3 | 1 | 0 | 0 | 0 | 0 | 0 |
| CTX-M-15 + TEM-1 | 1 | 0 | 0 | 0 | 0 | 0 |
| CTX-M-15 + SHV-11 | 1 | 0 | 0 | 0 | 0 | 0 |
| Undetermined | 5 | 0 | 0 | 0 | 2 | 0 |
*
HV: hypermucoviscosity phenotype.